[1]
Ali A, Ahmad FJ, Pillai KK, Vohora D. Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior. Epilepsy Behav 2004; 5: 322-8.
[2]
Deng X, Xie Y, Chen Y. Effect of neuroinflammation on ABC transporters. Possible contribution to refractory epilepsy. CNS Neurol Disord Drug Targets 2018; 17: 728-35.
[3]
Ying X, Wang Y, Liang J, et al. Angiopep-conjugated electro-responsive hydrogel nanoparticles: Therapeutic potential for epilepsy. Angew Chem Int Ed Engl 2014; 53: 12436-40.
[4]
Shuzhang Z, Yudan Z, Zhiping Z, Jie T, Yong-Hua J. Understanding genotypes and phenotypes of the mutations in voltage- gated sodium channel α subunits in epilepsy. CNS Neurol Disord Drug Targets 2018; 17: 1-7.
[5]
Ohno Y, Tokudome K. Therapeutic role of Synaptic Vesicle glycoprotein 2A (SV2A) in modulating epileptogenesis. CNS Neurol Disord Drug Targets 2017; 16: 463-71.
[6]
Witkin JM, Schober DA, Gleason SD, et al. Targeted Blockade of TARP-γ8-associated AMPA receptors: Anticonvulsant activity with the selective antagonist LY3130481 (CERC-611). CNS Neurol Disord Drug Targets 2017; 16: 1099-110.
[7]
Shiha AA, de la Rosa RF, Delgado M, Pozo MA, García-García L. Subacute fluoxetine reduces signs of hippocampal damage induced by a single convulsant dose of 4-aminopyridine in rats. CNS Neurol Disord Drug Targets 2017; 16: 694-704.
[8]
Lerche H, Shah M, Beck H, Noebels J, Johnston D, Vincent A. Ion channels in genetic and acquired forms of epilepsy. J Physiol 2013; 591: 753-64.
[9]
Zhu Y, Zhang S, Feng Y, Xiao Q, Cheng J, Tao J. The Yin and Yang of BK channels in epilepsy. CNS Neurol Disord Drug Targets 2018; 17: 272-9.
[10]
Zang K, Zhang Y, Hu J, Wang Y. The large conductance calcium- and voltage-activated potassium channel (BK) and epilepsy. CNS Neurol Disord Drug Targets 2018; 17: 248-54.
[11]
Pruss H, Derst C, Lommel R, Veh RW. Differential distribution of individual subunits of strongly inwardly rectifying potassium channels (Kir2 family) in rat brain. Brain Res Mol Brain Res 2005; 139: 63-79.
[12]
Bedner P, Steinhauser C. Altered Kir and gap junction channels in temporal lobe epilepsy. Neurochem Int 2013; 63: 682-7.
[13]
Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels, their structure, function, and physiological roles. Physiol Rev 2010; 90: 291-366.
[14]
de Boer TP, Houtman MJ, Compier M, van der Heyden MA. The mammalian K(IR)2.x inward rectifier ion channel family, expression pattern and pathophysiology. Acta Physiol (Oxf) 2010; 199: 243-56.
[15]
Murata Y, Yasaka T, Takano M, Ishihara K. Neuronal and glial expression of inward rectifier potassium channel subunits Kir2.x in rat dorsal root ganglion and spinal cord. Neurosci Lett 2016; 617: 59-65.
[16]
Xu L, Hao Y, Wu X, Yu P, Zhu G, Hong Z. Tenidap, an agonist of the inwardly rectifying K+ channel Kir2.3, delays the onset of cortical epileptiform activity in a model of chronic temporal lobe epilepsy. Neurol Res 2013; 35: 561-7.
[17]
Madhok R Tenidap. Lancet 1995; 346(8973): 481-5.
[18]
Liu Y, Liu D, Printzenhoff D, Coghlan MJ, Harris R, Krafte DS. Tenidap, a novel anti-inflammatory agent, is an opener of the inwardly rectifying K+ channel hKir2.3. Eur J Pharmacol 2002; 435: 153-60.
[19]
Chen B, Jiang M, Zhou M, et al. Both NMDA and non-NMDA receptors mediate glutamate stimulation induced cofilin rod formation in cultured hippocampal neurons. Brain Res 2012; 1486: 1-13.
[20]
Chen L, Wan L, Wu Z, et al. KCC2 downregulation facilitates epileptic seizures. Sci Rep 2017; 7: 156.
[21]
Sun Y, Wu Z, Kong S, et al. Regulation of epileptiform activity by two distinct subtypes of extrasynaptic GABAA receptors. Mol Brain 2013; 6: 21.
[22]
Qi J, Wang Y, Jiang M, Warren P, Chen G. Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo. J Physiol 2006; 571: 605-18.
[23]
Stafstrom CE, Carmant L. Seizures and epilepsy: An overview for neuroscientists. Cold Spring Harb Perspect Med 2015; 5pii: a022426
[24]
Naseer MI, Rasool M, Chaudhary AG, et al. Chromosomal micro-aberration in a Saudi family with juvenile myoclonic epilepsy. CNS Neurol Disord Drug Targets 2017; 16: 1010-7.
[25]
Jiang XW, Lu HY, Xu Z, et al. In Silicoanalyses for key genes and molecular genetic mechanism in epilepsy and Alzheimer’s disease. CNS Neurol Disord Drug Targets 2018; 17: 608-17.
[26]
Hille B. Ionic channels in excitable membranes. Current problems and biophysical approaches. Biophys J 1978; 22: 283-94.
[27]
Perier F, Radeke CM, Vandenberg CA. Primary structure and. characterization of a small-conductance inwardly rectifying potassium channel from human hippocampus. Proc Natl Acad Sci USA 1994; 91: 6240-4.
[28]
Tang XH, Wu XY, Xu L, et al. Tenidap is neuroprotective in a pilocarpine rat model of temporal lobe epilepsy. Chin Med J (Engl) 2013; 126: 1900-5.
[29]
Zhang S, Zhu Y, Zhang Z, Tao J, Ji Y. Understanding genotypes and phenotypes of voltage-gated sodium channel mutations in epilepsy. CNS Neurol Disord Drug Targets 2018; 18(4): 266-72.
[30]
Leo A, Citraro R, Marra R, et al. The sphingosine 1-phosphate signaling pathway in epilepsy. A possible role for the immunomodulator drug fingolimod in epilepsy treatment. CNS Neurol Disord Drug Targets 2017; 16: 311-25.
[31]
Ruppersberg JP. Intracellular regulation of inward rectifier K+ channels. Pflugers Arch 2000; 441: 1-11.
[32]
Wang WH. Regulation of the hyperpolarization-activated K+ channel in the lateral membrane of the cortical collecting duct. J Gen Physiol 1995; 106: 25-43.
[33]
Fisher RS, Pedley TA, Moody WJ Jr, Prince DA. The role of extracellular potassium in hippocampal epilepsy. Arch Neurol 1976; 33: 76-83.
[34]
Lothman EW, Somjen GG. Functions of primary afferents and responses of extracellular K+ during spinal epileptiform seizures. Electroencephalogr Clin Neurophysiol 1976; 41: 253-67.
[35]
Traynelis SF, Dingledine R. Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice. J Neurophysiol 1988; 59: 259-76.
[36]
Best L, Brown PD, Sener A, Malaisse WJ. Opposing effects of tenidap on the volume-regulated anion channel and K(ATP) channel activity in rat pancreatic beta-cells. Eur J Pharmacol 2010; 629: 159-63.
[37]
Cleveland PL, Millard PJ, Showell HJ, Fewtrell CM. Tenidap, a novel inhibitor of calcium influx in a mast cell line. Cell Calcium 1993; 14: 1-16.